{
  "meta": {
    "title": "30_Malignant_Tumors_Of_Liver",
    "url": "https://brainandscalpel.vercel.app/30-malignant-tumors-of-liver-558c9903.html",
    "scrapedAt": "2025-11-30T12:36:01.096Z"
  },
  "questions": [
    {
      "text": "Patients with hepatocellular carcinoma are least likely to present with ______.",
      "choices": [
        {
          "id": 1,
          "text": "Abdominal pain"
        },
        {
          "id": 2,
          "text": "Jaundice"
        },
        {
          "id": 3,
          "text": "Weight loss"
        },
        {
          "id": 4,
          "text": "Palpable mass"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Jaundice is an uncommon sign of hepatocellular carcinoma (HCC).</p>\n<p><strong>Hepatocellular carcinoma</strong> is the <strong>most common primary malignancy</strong>&nbsp;of the <strong>liver.</strong>&nbsp;It is commonly seen in men aged 50-60 years who present with&nbsp;right upper quadrant abdominal pain,&nbsp;weight loss, and a palpable mass.</p>\n<p>Non-specific symptoms of the advanced malignant disease are anorexia, nausea, lethargy.&nbsp;The gross appearance shows <strong>unifocal</strong> or <strong>multifocal</strong> or <strong>diffusely</strong> <strong>infiltrative</strong> lesions that are paler than the surrounding tissue.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7498",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a risk factor for hepatocellular carcinoma?",
      "choices": [
        {
          "id": 1,
          "text": "Oral contraceptive pills use"
        },
        {
          "id": 2,
          "text": "Non-alcoholic steatohepatitis"
        },
        {
          "id": 3,
          "text": "Hepatitis B"
        },
        {
          "id": 4,
          "text": "Primary biliary cirrhosis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Oral contraceptive use</strong> is not an independent risk factor for hepatocellular carcinoma. It is a risk factor for developing <strong>hepatic adenoma</strong>.&nbsp;</p>\n<p>Although hepatocellular adenoma can undergo malignant transformation, the true risk is low (10%).</p>\n<p><strong>Major risk factors for hepatocellular carcinoma:</strong></p>\n<ul>\n<li>Infection:\n<ul>\n<li>Hepatitis B</li>\n<li>Hepatitis C</li>\n</ul>\n</li>\n<li>Toxins/drugs:\n<ul>\n<li>Alcoholic cirrhosis</li>\n<li>Aflatoxins</li>\n<li>Anabolic steroids</li>\n</ul>\n</li>\n<li>Genetic:\n<ul>\n<li>Hemochromatosis</li>\n<li>&alpha;1-Antitrypsin deficiency</li>\n</ul>\n</li>\n<li>Immunological:\n<ul>\n<li>Autoimmune chronic active hepatitis</li>\n<li>Primary biliary cirrhosis</li>\n</ul>\n</li>\n<li>Others:\n<ul>\n<li>Obesity</li>\n<li>Nonalcoholic steatohepatitis</li>\n<li>Cirrhosis (other causes and idiopathic).</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7503",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following can be seen with HCC?",
      "choices": [
        {
          "id": 1,
          "text": "Hypercalcemia"
        },
        {
          "id": 2,
          "text": "Hyperglycemia"
        },
        {
          "id": 3,
          "text": "Hyponatremia"
        },
        {
          "id": 4,
          "text": "Hyperkalemia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Paraneoplastic syndrome</strong>&nbsp;due to&nbsp;<strong>hepatocellular carcinoma</strong>&nbsp;can manifest as:</p>\n<ul>\n<li><strong>Hypercalcemia</strong></li>\n<li>Hypoglycemia</li>\n<li>Erythrocytosis</li>\n</ul>\n<p>Hypercalcemia in patients with HCC is associated with&nbsp;<strong>increased renal reabsorption </strong>of calcium&nbsp;and <strong>increased bone resorption</strong>&nbsp;by parathyroid hormone-related protein (<strong>PTHrP</strong>) generated by HCC.<span class=\"Apple-converted-space\">&nbsp;</span></p>\n<p><span class=\"Apple-converted-space\">Less than 1% of cases of HCC manifest with a paraneoplastic syndrome.</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7519",
      "difficulty": "easy"
    },
    {
      "text": "A 57-year-old man presented with persistent upper abdominal pain and weight loss. Ultrasound revealed a lesion in the right lobe of the liver and contrast-enhanced CT was suggestive of hepatocellular carcinoma. Which of the following tumor markers can be elevated in this patient?<div class='question-desc-html'><ol>\n<li aria-level=\"1\">Alpha fetoprotein&nbsp;</li>\n<li aria-level=\"1\">PIVKA-2</li>\n<li aria-level=\"1\">Alpha-2-macroglobulin</li>\n<li aria-level=\"1\">Glypican&nbsp;</li>\n<li aria-level=\"1\">Neurotensin</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1 and 5"
        },
        {
          "id": 2,
          "text": "1, 2, 4 and 5"
        },
        {
          "id": 3,
          "text": "3 and 5"
        },
        {
          "id": 4,
          "text": "2, 3 and 4"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Alpha-2-macroglobulin is not a tumor marker of HCC.&nbsp;</p>\n<p>Tumor markers of HCC are:</p>\n<ul>\n<li><strong>Alpha-fetoprotein (AFP)</strong><strong><br /> </strong></li>\n<ul>\n<li>Normal (&lt;20 ng/mL),</li>\n<li>Elevated (21&ndash;400 ng/mL), and</li>\n<li>Diagnostic for <strong>HCC</strong> (<strong>&gt;400 ng/mL</strong>).&nbsp;</li>\n</ul>\n<li>Protein Induced by Vitamin K Absence or Antagonist - II<strong> (PIVKA-II) </strong>also called des-gamma-carboxy prothrombin (DCP)</li>\n<li>Glypican 3.</li>\n<li>Neurotensin (in fibrolamellar type)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7514",
      "difficulty": "easy"
    },
    {
      "text": "A 43-year-old man presented to the hospital with complaints of abdominal pain, ascites, and weight loss for 6 months. Investigations revealed a thrombus in the portal vein along with invasion from nearby tumor growth. Which of the following conditions can cause this?",
      "choices": [
        {
          "id": 1,
          "text": "Hepatic adenoma"
        },
        {
          "id": 2,
          "text": "Hepatocellular carcinoma"
        },
        {
          "id": 3,
          "text": "Focal nodular hyperplasia"
        },
        {
          "id": 4,
          "text": "Cavernous hemangioma"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In the above clinical scenario, the patient has a <strong>secondary Budd-Chiari syndrome</strong> due to portal vein obstruction by a neighboring invasive lesion. <strong>Hepatocellular carcinoma </strong>(HCC) has the <strong>highest</strong>&nbsp;<strong>tendency to invade </strong>the<strong> portal vein.</strong></p>\n<p>Budd&ndash;Chiari syndrome (BCS) is an uncommon congestive hepatopathy characterized by the obstruction of hepatic venous outflow.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7517",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not true regarding the fibrolamellar variant of HCC?",
      "choices": [
        {
          "id": 1,
          "text": "Commonly associated with cirrhosis"
        },
        {
          "id": 2,
          "text": "Recurrences are seen despite better prognosis"
        },
        {
          "id": 3,
          "text": "Occur under the age of 35 years"
        },
        {
          "id": 4,
          "text": "Not commonly associated with chronic hepatitis B infection"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Fibrolamellar</strong> variant of <strong>HCC</strong> is not commonly associated with liver cirrhosis.</p>\n<p>Fibrolamellar carcinoma is a distinctive variant (&lt;5%) of HCC. They occur under the age of 35 years, without any gender predilection or identifiable predisposing conditions.&nbsp;</p>\n<p>It usually presents as a single large, hard 'scirrhous' tumor. The tumor is well-demarcated, encapsulated, and may have a <strong>central fibrotic area</strong>. Histology shows large polygonal cells embedded in a <strong>fibrous stroma</strong> forming<strong> lamellar structures</strong>.</p><p>Fibrolamellar HCC has<strong>&nbsp;</strong>a<strong> better prognosis</strong> compared to HCC due to high resectability, but recurrences are seen despite this. Lymph node metastasis may be seen.</p><hr><h3>Related Pearl: Differentiating features between hepatocellular carcinoma (HCC) and fibrolamellar carcinoma</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Parameter</strong></p>\n</td>\n<td>\n<p><strong>HCC</strong></p>\n</td>\n<td>\n<p><strong>Fibrolamellar carcinoma</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Male-to-female ratio</p>\n</td>\n<td>\n<p>2:1&nbsp; to&nbsp;8:1</p>\n</td>\n<td>\n<p>No gender predilection</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Median age</p>\n</td>\n<td>\n<p>55 years</p>\n</td>\n<td>\n<p>25 years</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tumor&nbsp;</p>\n</td>\n<td>\n<p>Invasive</p>\n</td>\n<td>\n<p>&nbsp;Well circumscribed</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Resectability</p>\n</td>\n<td>\n<p>&lt;25%</p>\n</td>\n<td>\n<p>50%&ndash;75%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cirrhosis</p>\n</td>\n<td>\n<p>90%</p>\n</td>\n<td>\n<p>5%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>AFP positive</p>\n</td>\n<td>\n<p>80%</p>\n</td>\n<td>\n<p>5%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis B positive</p>\n</td>\n<td>\n<p>65%</p>\n</td>\n<td>\n<p>5%</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>AFP: alpha-fetoprotein&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7509",
      "difficulty": "medium"
    },
    {
      "text": "A 25-year-old male patient is found to have a well-circumscribed mass in his liver and is suspected to have fibrolamellar HCC. Which of the following tumor markers will be elevated in his condition?",
      "choices": [
        {
          "id": 1,
          "text": "AFP"
        },
        {
          "id": 2,
          "text": "Neurotensin"
        },
        {
          "id": 3,
          "text": "ALP"
        },
        {
          "id": 4,
          "text": "Glypican-3"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Neurotensin</strong> is the <strong>tumor marker</strong> of <strong>fibrolamellar</strong> hepatocellular carcinoma (HCC).</p>\n<p>Neurotensin is a <strong>mitogen</strong> which<strong> induces cell proliferation</strong> in fibrolamellar hepatocellular carcinoma.&nbsp;There is increased serum unsaturated vitamin B12 binding capacity seen in fibrolamellar HCC which can also aid in diagnosis.</p><hr><h3>Related Pearl: Differentiating features between hepatocellular carcinoma (HCC) and fibrolamellar carcinoma</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Parameter</strong></p>\n</td>\n<td>\n<p><strong>HCC</strong></p>\n</td>\n<td>\n<p><strong>Fibrolamellar carcinoma</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Male-to-female ratio</p>\n</td>\n<td>\n<p>2:1&nbsp; to&nbsp;8:1</p>\n</td>\n<td>\n<p>No gender predilection</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Median age</p>\n</td>\n<td>\n<p>55 years</p>\n</td>\n<td>\n<p>25 years</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tumor&nbsp;</p>\n</td>\n<td>\n<p>Invasive</p>\n</td>\n<td>\n<p>&nbsp;Well circumscribed</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Resectability</p>\n</td>\n<td>\n<p>&lt;25%</p>\n</td>\n<td>\n<p>50%&ndash;75%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cirrhosis</p>\n</td>\n<td>\n<p>90%</p>\n</td>\n<td>\n<p>5%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>AFP positive</p>\n</td>\n<td>\n<p>80%</p>\n</td>\n<td>\n<p>5%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis B positive</p>\n</td>\n<td>\n<p>65%</p>\n</td>\n<td>\n<p>5%</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>AFP: alpha-fetoprotein&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7499",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is not true about alpha-fetoprotein?",
      "choices": [
        {
          "id": 1,
          "text": "AFP level does not return back to normal after hepatic resection"
        },
        {
          "id": 2,
          "text": "Levels  of >400 ng/mL with typical radiological findings is suggestive of HCC"
        },
        {
          "id": 3,
          "text": "AFP level can be raised in benign conditions"
        },
        {
          "id": 4,
          "text": "Fibrolamellar HCC has normal levels"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Alpha-fetoprotein</strong> (AFP) level returns to<strong> normal after resection</strong>.</p>\n<p><strong>Alpha-fetoprotein </strong>is a glycoprotein that is produced in early fetal life by the liver. It is also produced by a variety of tumors, such as:</p>\n<ul>\n<li>Hepatocellular carcinoma</li>\n<li>Hepatoblastoma</li>\n<li>Non-seminomatous germ cell tumors of the ovary and testis (e.g., yolk sac and embryonal carcinoma).</li>\n</ul>\n<p>AFP is also elevated during the following conditions:</p>\n<ul>\n<li>Pregnancy and in benign liver disease (e.g., viral hepatitis, cirrhosis)</li>\n<li>Gastrointestinal tract tumors</li>\n<li>Along with carcinoembryonic antigen in ataxia-telangiectasia</li>\n</ul>\n<p>Limitations of AFP include<strong>&nbsp;</strong>low sensitivity and specificity. It&nbsp;is <strong>not specific</strong> to HCC and can occur with intrahepatic cholangiocarcinoma and colorectal metastases.</p>\n<p><strong>Levels &gt;400 ng/mL </strong>with typical radiological findings are suggestive of <strong>HCC</strong>.&nbsp;Alpha-fetoprotein (AFP) is <strong>not elevated</strong> in <strong>fibrolamellar</strong> <strong>HCC.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7507",
      "difficulty": "medium"
    },
    {
      "text": "AFP is used as a tumor marker in which of the following cancers?<div class='question-desc-html'><ol>\n<li>Yolk sac tumor</li>\n<li>Hepatoblastoma</li>\n<li>Cholangiocarcinoma</li>\n<li>Fibrolamellar HCC</li>\n<li>HCC</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2 and 3"
        },
        {
          "id": 2,
          "text": "3, 4 and 5"
        },
        {
          "id": 3,
          "text": "1 and 3"
        },
        {
          "id": 4,
          "text": "1, 2 and 5"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Alpha-fetoprotein </strong>(AFP) is not a tumor marker used to detect<strong>&nbsp;</strong>cholangiocarcinoma or fibrolamellar HCC.</p>\n<p>It is produced by a variety of tumors such as:</p>\n<ul>\n<li>Hepatocellular carcinoma (<strong>HCC</strong>)</li>\n<li><strong>Hepatoblastoma</strong></li>\n<li>Non-seminomatous germ cell tumors of the ovary and testis (e.g., <strong>yolk sac</strong> and <strong>embryonal carcinoma</strong>).</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7500",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following are modalities of treatment in patients with hepatocellular carcinoma?<div class='question-desc-html'><ol>\n<li aria-level=\"1\">Radiofrequency ablation</li>\n<li aria-level=\"1\">Thermal ablation</li>\n<li aria-level=\"1\">Transarterial chemoembolization</li>\n<li aria-level=\"1\">Percutaneous ethanol injection </li>\n<li aria-level=\"1\">Liver transplantation</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2, 4"
        },
        {
          "id": 2,
          "text": "1 and 5"
        },
        {
          "id": 3,
          "text": "1, 3, 5"
        },
        {
          "id": 4,
          "text": "1, 2, 3, 4 and 5"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>All of the given modalities can be used for the treatment of HCC.</p>\n<p>Treatment options for hepatocellular carcinoma (HCC):</p>\n<ul>\n<li><strong>Surgical</strong></li>\n<ul>\n<li><strong>Resection</strong> (the mainstay of treatment)</li>\n<li>Orthotopic liver transplantation </li>\n</ul>\n<li><strong>Ablative</strong></li>\n<ul>\n<li>Percutaneous ethanol injection (PEI) (less frequently used nowadays)</li>\n<li>Thermal ablation (cryotherapy, radiofrequency ablation, microwave, Nd-YAG laser)</li>\n</ul>\n<li><strong>Transarterial</strong></li>\n<ul>\n<li>Embolization</li>\n<li>Chemoembolization</li>\n</ul>\n<li><strong>Radiotherapy</strong></li>\n<ul>\n<li>Combination of transarterial and ablative: external beam radiation</li>\n</ul>\n<li><strong>Systemic</strong></li>\n<ul>\n<li>Chemotherapy</li>\n<li>Hormonal</li>\n<li>Immunotherapy</li>\n</ul>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7516",
      "difficulty": "medium"
    },
    {
      "text": "A 50-year-old man has been diagnosed with localized hepatocellular carcinoma. He falls into child-pugh class A and his future liver remnant is 22% of the total liver volume. Which of the following will decrease the tumor burden and improve his hepatic functional reserve?",
      "choices": [
        {
          "id": 1,
          "text": "Resection followed by chemotherapy"
        },
        {
          "id": 2,
          "text": "Preoperative portal vein embolization followed by resection"
        },
        {
          "id": 3,
          "text": "Radiotherapy, followed by chemotherapy"
        },
        {
          "id": 4,
          "text": "Intralesional ethanol"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The patient should ideally be treated by preoperative <strong>portal vein embolization</strong> to <strong>improve hepatic functional reserve</strong>, followed by <strong>resection</strong> which will <strong>decrease</strong> the <strong>tumor burden. </strong></p>\n<p>Portal venous embolization on the side of the tumor will lead to <strong>compensatory hypertrophy</strong> of the unaffected liver lobe. This improves the volume and function of the future liver remnant (FLR).</p>\n<p><strong>Localized hepatocellular carcinoma</strong></p>\n<ul>\n<li>&nbsp;<strong>Child-Pugh class A</strong>: Patients with child-pugh class A should undergo resection of the tumor.\n<ul>\n<li aria-level=\"2\">Those with<strong> low FLR (&lt;30%)</strong> should ideally be treated by preoperative <strong>portal vein embolization</strong> followed by<strong> resection</strong>. Preoperative embolization helps in improving the FLR volume function prior to resection.</li>\n<li aria-level=\"2\">Those with <strong>adequate FLR (&gt;30-40%)</strong> can usually tolerate <strong>resection</strong> alone.</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li aria-level=\"2\"><strong>Child-Pugh class B/C or portal hypertension</strong>: Patients with early-stage HCC and child-Pugh class B/C or portal hypertension should be considered for <strong>transplantation</strong>.</li>\n</ul>\n<p>&nbsp;<strong>Advanced hepatocellular carcinoma</strong></p>\n<p>&nbsp;Patients with advanced hepatocellular carcinoma are treated with palliative intent. Following are the management options:</p>\n<ul>\n<li aria-level=\"2\">Drug therapy - Sorafenib/ Sunitinib/ Regorafenib</li>\n<li aria-level=\"2\">Transarterial chemoembolisation<strong> (TACE)</strong> and transarterial radioembolisation <strong>(TARE)</strong> offer the best results in multifocal disease</li>\n<li aria-level=\"2\">Radiofrequency ablation, microwave ablation, high-frequency ultrasound therapy are alternative options</li>\n<li aria-level=\"2\">Patients with extreme deterioration of performance status and liver function should be offered supportive treatment only.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4032",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following parameters is not considered in OKUDA staging?",
      "choices": [
        {
          "id": 1,
          "text": "Bilirubin"
        },
        {
          "id": 2,
          "text": "Tumor size"
        },
        {
          "id": 3,
          "text": "Ascites"
        },
        {
          "id": 4,
          "text": "AFP"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>OKUDA staging</strong> includes assessment of all the above factors except alpha-fetoprotein (AFP).</p>\n<p>The OKUDA staging system distinguishes patients with&nbsp;poor<strong> prognosis</strong> from those with more potential for long-term survival. The OKUDA staging system is an older system.</p>\n<p>OKUDA staging system for hepatocellular carcinoma (HCC):</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Clinical parameter</strong></p>\n</td>\n<td>\n<p><strong>Cut-off value</strong></p>\n</td>\n<td>\n<p><strong>Points</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Serum&nbsp;bilirubin</p>\n</td>\n<td>\n<p>&lt;3</p>\n<p>&gt;3</p>\n</td>\n<td>\n<p>0</p>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Serum albumin</p>\n</td>\n<td>\n<p>&gt;3</p>\n<p>&lt;3</p>\n</td>\n<td>\n<p>0</p>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tumor size</p>\n</td>\n<td>\n<p>&lt;50%</p>\n<p>&gt;50%</p>\n</td>\n<td>\n<p>0</p>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascites</p>\n</td>\n<td>\n<p>Absent</p>\n<p>Present</p>\n</td>\n<td>\n<p>0</p>\n<p>1</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Stage I: 0 points</p>\n<p>Stage II: 1-2 points</p>\n<p>Stage III: 3-4 points</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7510",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following scoring systems will you not use to assess oncological outcomes of patients with hepatocellular carcinoma?",
      "choices": [
        {
          "id": 1,
          "text": "MELD"
        },
        {
          "id": 2,
          "text": "BCLC"
        },
        {
          "id": 3,
          "text": "CLIP"
        },
        {
          "id": 4,
          "text": "OKUDA"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>MELD (model for end-stage liver disease) score is <strong>not used </strong>to assess the oncological outcome of patients<strong>&nbsp;</strong>with hepatocellular carcinoma.&nbsp;<strong>MELD</strong> is used to predict the <strong>severity of end-stage chronic liver disease</strong>.</p>\n<p><strong>Barcelona Clinic Liver Cancer staging system</strong> (BCLC) is the <strong>most commonly used</strong> scoring system for staging and management of HCC.</p>\n<p>The staging or management of HCC is done by the following:</p>\n<p>1. Barcelona Clinic Liver Cancer staging system (BCLC)</p>\n<ul>\n<li>Tumor score (TNM)</li>\n<li>Child-Pugh score</li>\n<li>Performance score(Barcelona clinic score)</li>\n</ul>\n<p>&nbsp;2.&nbsp;Cancer of the Liver Italian Program (CLIP)&nbsp;</p>\n<ul>\n<li>Tumor size</li>\n<li>Child-Pugh score</li>\n<li>AFP</li>\n<li>Portal vein thrombosis</li>\n</ul>\n<p>3. OKUDA staging</p>\n<ul>\n<li><strong>B</strong>ilirubin</li>\n<li><strong>A</strong>scites</li>\n<li><strong>T</strong>umor size</li>\n<li><strong>A</strong>lbumin</li>\n</ul>\n<p>4. Chinese University Prognostic Index (CUPI)</p>\n<p>Note: MELD can be used in prioritizing HCC patients in need of liver transplants.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7511",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is true regarding LI-RADS scoring?",
      "choices": [
        {
          "id": 1,
          "text": "LI-RADS 2 has an intermediate probability of malignancy"
        },
        {
          "id": 2,
          "text": "Treatment for hepatocellular carcinoma can be initiated in LI-RADS 5 without biopsy"
        },
        {
          "id": 3,
          "text": "LI-RADS 3 is an indication for immediate liver biopsy"
        },
        {
          "id": 4,
          "text": "LI-RADS 4 is definitive of hepatocellular carcinoma"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>LI-RADS 5 indicates a <strong>definitive probability</strong>(~100%) of&nbsp; hepatocellular carcinoma. Therefore treatment can be initiated as early as possible without waiting for a biopsy.</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">Liver Imaging Reporting and Data Systems (LI-RADS) categories&nbsp;</td>\n</tr>\n<tr>\n<td>Category</td>\n<td>Assessment</td>\n</tr>\n<tr>\n<td>LI-RADS 1</td>\n<td>Definitely benign</td>\n</tr>\n<tr>\n<td>LI-RADS 2</td>\n<td>Probably benign</td>\n</tr>\n<tr>\n<td>LI-RADS 3</td>\n<td>Intermediate probability of malignancy</td>\n</tr>\n<tr>\n<td>LI-RADS 4</td>\n<td>Probably HCC</td>\n</tr>\n<tr>\n<td>LI-RADS 5</td>\n<td>Definitely HCC</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li><strong>Routine surveillance</strong> should be continued for LI-RADS <strong>1, 2</strong>. Additional imaging may be required for LI-RADS 2 based on individual risk.</li>\n<li>LI-RADS <strong>3</strong> should be evaluated by <strong>serial imaging</strong> every 3-6 months.</li>\n<li>Evaluation with a <strong>biopsy</strong> should be done in LI-RADS <strong>4</strong>.</li>\n<li>Since LI-RADS <strong>5</strong> indicates a definitive probability of hepatocellular carcinoma, <strong>treatment</strong> can be initiated as early as possible without waiting for a biopsy.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4044",
      "difficulty": "medium"
    },
    {
      "text": "A 70-year-old retiree was employed for two decades in a plastic industry, where he was exposed to vinyl chloride. He is at an increased risk of developing which of the following tumors?",
      "choices": [
        {
          "id": 1,
          "text": "Hepatocellular carcinoma"
        },
        {
          "id": 2,
          "text": "Angiosarcoma of liver"
        },
        {
          "id": 3,
          "text": "Clear cell HCC"
        },
        {
          "id": 4,
          "text": "Intrahepatic cholangiocarcinoma"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Angiosarcoma </strong>of the liver is seen in workers who have been&nbsp;exposed to<strong> vinyl chloride</strong> for prolonged periods.</p>\n<p>Angiosarcoma is the <strong>most common</strong> malignant <strong>mesenchymal tumor</strong> of the liver. It is a rare and fatal tumor.</p>\n<p>They are associated with the following conditions:</p>\n<ul>\n<li>Hemochromatosis</li>\n<li>Neurofibromatosis type I</li>\n<li>Exposure to vinyl chloride, thorium dioxide, and arsenic.</li>\n</ul>\n<p>Patients usually present with<strong> vague symptoms</strong> of abdominal pain, weakness, fatigue, and weight loss. A <strong>hepatic bruit</strong> is occasionally heard, reflecting the vascular nature of the tumor.</p>\n<p>Central hypovascularity, vascular lakes, and <strong>peripheral contrast staining</strong> on arteriography are suggestive of an angiosarcoma. Biopsy shows the presence of dilated sinusoids lined by atypical endothelial cells.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7502",
      "difficulty": "medium"
    },
    {
      "text": "An infant is brought to the hospital by his parents with complaints of poor feeding and abdominal distension. On evaluation, a mass is detected in the liver which is later diagnosed to be a hepatoblastoma. Which of the following is false regarding this condition?",
      "choices": [
        {
          "id": 1,
          "text": "It is associated with familial adenomatous polyposis"
        },
        {
          "id": 2,
          "text": "Most cases occur before the age of 3 years"
        },
        {
          "id": 3,
          "text": "Treatment is surgical resection followed by chemotherapy "
        },
        {
          "id": 4,
          "text": "Prognosis is extremely poor for pulmonary metastasis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In <strong>hepatoblastoma,</strong> 85%&nbsp;of patients with pulmonary metastases can be successfully <strong>treated </strong>with<strong> resection </strong>of the <strong>hepatic tumor</strong> and <strong>chemotherapy</strong> <strong>or resection</strong> of the <strong>pulmonary metastases.</strong></p>\n<p>Hepatoblastoma is the <strong>most common </strong>primary hepatic <strong>tumor of childhood. </strong>The median&nbsp;age at presentation is 18 months, and almost all cases occur<strong> before 3 years </strong>of age. It has been associated with&nbsp;<strong>familial adenomatous polyposis</strong> (FAP) syndrome.</p>\n<p>This tumor generally manifests as an <strong>asymptomatic mass.</strong> Mild anemia and thrombocytosis are commonly found at presentation.</p>\n<p>Serum<strong> alpha-fetoprotein </strong>(AFP) levels are <strong>elevated</strong> in the majority of patients and can serve as a useful marker for therapeutic response.</p>\n<p>Treatment includes <strong>chemotherapy</strong> that can help downstage tumors such that they are amenable to <strong>resection</strong>. In patients without metastatic disease or the anaplastic variant, long-term survival rates of 60% to 70% can be expected with complete resection.</p>\n<p>Staging of pediatric liver tumors:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Stage</strong></p>\n</td>\n<td>\n<p><strong>Feature</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Stage I</p>\n</td>\n<td>\n<p>No metastases</p>\n<p>Tumor completely resected</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Stage II</p>\n</td>\n<td>\n<p>No metastases</p>\n<p>Tumor grossly resected with microscopic residual disease, or tumor rupture/spill at the time of surgery</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Stage III</p>\n</td>\n<td>\n<p>No distant metastases</p>\n<p>Tumor unresectable or resected with gross residual tumor, or positive lymph nodes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Stage IV</p>\n</td>\n<td>\n<p>Distant metastases regardless of the extent of liver involvement</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7520",
      "difficulty": "medium"
    },
    {
      "text": "A woman was diagnosed to have metastatic liver adenocarcinoma with CK 7 (-), CK20 (+), and CDX-1 (+) IHC markers. Which of the following is the most likely primary site of origin for this metastasis?",
      "choices": [
        {
          "id": 1,
          "text": "Colon carcinoma"
        },
        {
          "id": 2,
          "text": "Breast Carcinoma"
        },
        {
          "id": 3,
          "text": "Pancreatic carcinoma"
        },
        {
          "id": 4,
          "text": "Ovarian carcinoma"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Colorectal carcinoma</strong> is the <strong>most likely primary tumor</strong> for the given metastases. Among the given options, <strong>cytokeratin 7 </strong>is&nbsp;<strong>negative </strong>only in <strong>colon carcinoma</strong>.</p>\n<p>The <strong>most common site of distant metastasis</strong> of colorectal cancer is the <strong>liver.&nbsp;</strong>These metastases arise from <strong>hematogenous spread via the portal venous system</strong>. The lung is the next most common site for metastasis.</p>\n<p>Cytokeratin profiles of various primary tumors:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>CK 7 positive</p>\n<p>CK20 positive</p>\n</td>\n<td>\n<ul>\n<li>Cholangiocarcinoma</li>\n<li>Ovarian mucinous carcinoma</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>CK 7 <strong>positive&nbsp;</strong></p>\n<p>CK 20 negative</p>\n</td>\n<td>\n<ul>\n<li><strong>Breast carcinoma</strong></li>\n<li>Ovarian serous adenocarcinoma</li>\n<li><strong>Thyroid carcinoma</strong></li>\n<li>Pancreatic adenocarcinoma</li>\n<li><strong>Lung carcinoma</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>CK 7 <strong>negative</strong></p>\n<p>CK 20 <strong>positive</strong></p>\n</td>\n<td>\n<ul>\n<li><strong>Colorectal adenocarcinoma</strong></li>\n<li>Merkel cell carcinoma</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>CK 7 negative</p>\n<p>CK 20 negative</p>\n</td>\n<td>\n<ul>\n<li>Hepatocellular carcinoma</li>\n<li>Renal cell carcinoma</li>\n<li>Prostatic adenocarcinoma</li>\n<li>Squamous cell carcinoma</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6814",
      "difficulty": "medium"
    },
    {
      "text": "In patients with colorectal carcinoma, which of the following is not a bad prognostic factor?",
      "choices": [
        {
          "id": 1,
          "text": "Synchronous lesions"
        },
        {
          "id": 2,
          "text": "Multiple tumors"
        },
        {
          "id": 3,
          "text": "CEA level of >200 ng/mL"
        },
        {
          "id": 4,
          "text": "Metachronous lesions"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Metachronous lesions are not associated with a bad&nbsp;prognosis in case of liver metastasis from colon carcinoma.</p>\n<p>A <strong>metachronous </strong>cancer is defined as <strong>secondary cancer </strong>occurring <strong>more than 6 months</strong> after the index cancer.</p>\n<p><strong>Synchronous</strong> cancer is defined as <strong>two or more neoplasms</strong> identified <strong>simultaneously&nbsp;</strong>in the same patient, or a <strong>second tumor</strong> identified <strong>within&nbsp;six months </strong>after the initial diagnosis.</p>\n<p>Predictors of poor outcome in colorectal carcinoma with liver metastasis:</p>\n<ul>\n<li>Lymph-node-positive primary</li>\n<li>Disease-free interval &lt;12 months</li>\n<li>More than one tumor</li>\n<li>Tumor size &gt;5 cm</li>\n<li>Serum carcinoembryonic antigen (CEA) level &gt;200 ng/mL</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7529",
      "difficulty": "hard"
    },
    {
      "text": "Patients with which of the following conditions are not suitable for liver transplantation?",
      "choices": [
        {
          "id": 1,
          "text": "Cirrhosis"
        },
        {
          "id": 2,
          "text": "Primary biliary cirrhosis"
        },
        {
          "id": 3,
          "text": "Cholangiocarcinoma"
        },
        {
          "id": 4,
          "text": "Fulminant hepatitis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Cholangiocarcinoma</strong> is not an indication for a liver transplant.</p>\n<p>Orthotopic liver transplantation (OLT) for patients with cholangiocarcinoma had very<strong> poor results</strong> and this treatment strategy has largely been <strong>abandoned.</strong></p><hr><h3>Related Pearl: Indications of liver transplantation</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Adult</strong></p>\n</td>\n<td>\n<p><strong>Children</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Non-cholestatic (65%)</p>\n<ul>\n<li>Viral hepatitis B and C</li>\n<li>Alcoholic liver cirrhosis</li>\n<li>Cryptogenic</li>\n</ul>\n<p>Cholestatic (14%)</p>\n<ul>\n<li>Primary biliary cirrhosis</li>\n<li>Primary sclerosing cholangitis</li>\n</ul>\n<p>Autoimmune (5%)</p>\n<p>Malignant neoplasm (2%)</p>\n<p>Miscellaneous (14%)</p>\n</td>\n<td>\n<p>Biliary atresia (58%)</p>\n<p>Inborn errors of metabolism (11%)</p>\n<p>Cholestatic (9%)</p>\n<ul>\n<li>Primary sclerosing cholangitis</li>\n<li>Alagille syndrome</li>\n</ul>\n<p>Autoimmune (4%)</p>\n<p>Viral hepatitis (2%)</p>\n<p>Miscellaneous (16%)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7525",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common indication for liver transplant in children?",
      "choices": [
        {
          "id": 1,
          "text": "Biliary atresia"
        },
        {
          "id": 2,
          "text": "Indian childhood cirrhosis"
        },
        {
          "id": 3,
          "text": "Primary sclerosing cholangitis"
        },
        {
          "id": 4,
          "text": "Inborn errors of metabolism"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The most common indication for liver transplant in children is <strong>biliary atresia</strong>.&nbsp;</p>\n<p>In biliary atresia, the <strong>extrahepatic bile ducts are occluded</strong>, causing <strong>obstructive jaundice</strong> (conjugated hyper-bilirubinemia) and progressive <strong>liver fibrosis</strong> in early infancy. <strong>Liver transplantation</strong> is required if not diagnosed and managed early.</p>\n<p>(option B) Indian childhood cirrhosis (ICC) is a <strong>progressive liver failure </strong>in young children<strong>,</strong> associated with marked hepatic copper overload (in excess of 800 &mu;g/g dry weight). Unlike Wilson disease, ICC is associated with normal or elevated ceruloplasmin levels, indicating a defect late in the copper excretory pathway.</p><hr><h3>Related Pearl: Indications of liver transplantation</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Adult</strong></p>\n</td>\n<td>\n<p><strong>Children</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Non-cholestatic (65%)</p>\n<ul>\n<li>Viral hepatitis B and C</li>\n<li>Alcoholic liver cirrhosis</li>\n<li>Cryptogenic</li>\n</ul>\n<p>Cholestatic (14%)</p>\n<ul>\n<li>Primary biliary cirrhosis</li>\n<li>Primary sclerosing cholangitis</li>\n</ul>\n<p>Autoimmune (5%)</p>\n<p>Malignant neoplasm (2%)</p>\n<p>Miscellaneous (14%)</p>\n</td>\n<td>\n<p>Biliary atresia (58%)</p>\n<p>Inborn errors of metabolism (11%)</p>\n<p>Cholestatic (9%)</p>\n<ul>\n<li>Primary sclerosing cholangitis</li>\n<li>Alagille syndrome</li>\n</ul>\n<p>Autoimmune (4%)</p>\n<p>Viral hepatitis (2%)</p>\n<p>Miscellaneous (16%)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7522",
      "difficulty": "medium"
    },
    {
      "text": "A 5-year-old child with Wilson's disease is being considered for liver transplantation. Which of the following is not a parameter in the selection criteria for transplantation?",
      "choices": [
        {
          "id": 1,
          "text": "Age <10years"
        },
        {
          "id": 2,
          "text": "PT >100 s"
        },
        {
          "id": 3,
          "text": "Bilirubin >300 μmol/L"
        },
        {
          "id": 4,
          "text": "Jaundice less than 7 days before development of encephalopathy"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>A 5-year-old child with Wilson's disease is a case of <strong>non-paracetamol-induced acute liver failure</strong> and jaundice&nbsp;for <strong>more than 7 days</strong> before the development of encephalopathy is one of the parameters in the&nbsp;<strong>King's College criteria for liver transplantation.</strong></p>\n<p>It includes the following parameters:</p>\n<p><strong>Non-paracetamol-induced acute liver failure</strong>:</p>\n<div class=\"page\" title=\"Page 1177\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>PT &gt;100 s (INR &gt;6.5)</li>\n</ul>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; or/and</p>\n<ul>\n<li><strong>Any three</strong> of the following:\n<ul>\n<li>Age &lt;10 years or &gt;40 years</li>\n<li>Etiology non-A, non-B hepatitis, or idiosyncratic drug reaction</li>\n<li><strong>Jaundice more than 7 days before the development of encephalopathy</strong> i.e., not hyperacute</li>\n<li>PT &gt;50 s (INR &gt; 3.5)</li>\n<li>Bilirubin &gt; 18 mg/dl (300 &mu;mol/L)</li>\n</ul>\n</li>\n</ul>\n<p><strong>Paracetamol-induced acute liver failure:</strong></p>\n<div class=\"page\" title=\"Page 1177\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>pH &lt;7.30 (irrespective of the grade of encephalopathy)&nbsp;</li>\n</ul>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; or/and</p>\n<ul>\n<li><strong>All three</strong> of the following:\n<ul>\n<li>Prothrombin time &gt;100 s (INR &gt;6.5)</li>\n<li>Serum creatinine &gt;3.4 mg/dl (300 &mu;mol/L)</li>\n<li>Grade 3 or 4 hepatic encephalopathy</li>\n</ul>\n</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0848",
      "difficulty": "medium"
    },
    {
      "text": "Auxiliary orthotopic liver transplantation is indicated in which of the following conditions?",
      "choices": [
        {
          "id": 1,
          "text": "Drug induced hepatic failure"
        },
        {
          "id": 2,
          "text": "As standby procedure till a suitable donor is found"
        },
        {
          "id": 3,
          "text": "Acute fulminant liver failure that is irreversible"
        },
        {
          "id": 4,
          "text": "Metabolic liver disease"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Auxiliary</strong> orthotopic liver transplantation (A-OLTX) is indicated in <strong>non-cirrhotic metabolic liver disease</strong>.</p>\n<p>Auxiliary partial orthotopic liver transplantation is a technique where <strong>part</strong> of the&nbsp;<strong>diseased native liver</strong> is removed and <strong>replaced</strong> with<strong>&nbsp;</strong>a<strong> part </strong>of the<strong> healthy donor </strong>liver. This is done<strong>&nbsp;</strong>so the retained <strong>native liver</strong> can<strong> regenerate.&nbsp;</strong></p>\n<p>In selective cases of acute liver failure, auxiliary partial orthotopic liver transplantation could provide a chance for native liver regeneration and immunosuppression-free life.</p>\n<p>Auxillary orthotopic liver transplant is indicated for the following:</p>\n<ul>\n<li>Patients aged &lt;40 years</li>\n<li><strong>Reversible</strong> fulminant hepatic failure (auxiliary liver transplantation cannot be done in cases of irreversible liver failure)&nbsp;</li>\n<li><strong>Non-cirrhotic metabolic </strong>liver disease</li>\n<li>No hemodynamic instability</li>\n<li><strong>Hyperacute </strong>(not in other cases)&nbsp;Liver failure with Acetaminophen overdose.</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>Total orthotopic liver transplantation (OLTX)&nbsp;</strong></td>\n<td><strong>Auxiliary orthotopic liver transplantation (A-OLTX)</strong>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;The entire liver is transplanted&nbsp;</p>\n</td>\n<td>Only a portion of the liver is transplanted</td>\n</tr>\n<tr>\n<td>\n<p>Indications:</p>\n<ul>\n<li>Fulminant hepatic failure (FHF)</li>\n<li>Liver cirrhosis</li>\n<li>Primary biliary cirrhosis</li>\n</ul>\n</td>\n<td>\n<p>Indications:</p>\n<ul>\n<li>Crigler&ndash;Najjar syndrome type I</li>\n<li>Homozygous familial hypercholesterolemia</li>\n<li>Galactosemia&nbsp;</li>\n<li>Hereditary tyrosinemia&nbsp;</li>\n<li>Neimann-Pick's disease</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Life-long immunosuppression is required.</td>\n<td>Immunosuppression is required until the native liver regenerates</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Types of transplants</h3><table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>&nbsp;Definition</strong></td>\n</tr>\n<tr>\n<td><strong>Orthotopic</strong></td>\n<td>\n<p class=\"p1\">Organ implanted in the same anatomic location in the recipient as it was in the donor.&nbsp;Diseased organ is removed. Eg: heart, lung, liver, intestine</p>\n</td>\n</tr>\n<tr>\n<td><strong>Heterotopic</strong></td>\n<td>\n<p class=\"p1\">Organ implanted in a different anatomic location. Diseased organ is left in place. Eg: Kidney, pancreas</p>\n</td>\n</tr>\n<tr>\n<td><strong>Auxiliary transplantation</strong></td>\n<td>Partial tissue from the donor is used which acts as temporary support for the recipient's injured organ, which remains in place. Eg: left lobe of liver</td>\n</tr>\n<tr>\n<td><strong>Autotransplant&nbsp;</strong></td>\n<td>Transfer of cells/tissues/organs within the same person.&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Allotransplant</strong></td>\n<td>Transfer of cells/tissues/organs within the same species.&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Xenotransplant</strong></td>\n<td>Transfer of cells/tissues/organs in a different species.</td>\n</tr>\n<tr>\n<td><strong>Isograft</strong></td>\n<td>Transfer of organ or tissue within genetically identical individuals. Eg: Identical twins</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7524",
      "difficulty": "hard"
    }
  ]
}